Evidence map›Paper›PMID 21539809›Full record

ArticleBiochemical and biophysical research communications2011

Glutathione is a physiologic reservoir of neuronal glutamate.

Minori Koga, Anthony V Serritella, Marcus M Messmer, Akiko Hayashi-Takagi, Lynda D Hester, Solomon H Snyder, Akira Sawa, Thomas W Sedlak

Abstract read
In one paragraph

Article in Biochemical and biophysical research communications, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 71 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Metabolic Brain Disorders: Prodromes, Symptoms, and Syndromes.International journal of molecular sciences · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Oxidative Stress and Emergence of Psychosis.Antioxidants (Basel, Switzerland) · 2022
    Review
  12. Article
  13. Article
  14. Glutathione in Brain Disorders and Aging.Molecules (Basel, Switzerland) · 2022
    Review
  15. Oxidative medicine and cellular longevity · 2022
    Article
  16. Review
  17. Article
  18. Article
  19. Effectiveness of N-acetylcysteine in Treating Clinical Symptoms of Substance Abuse and Dependence: A Meta-analysis of Randomized Controlled Trials.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2021
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Minori KogaDepartment of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, Meyer 4-137, 600 North Wolfe Street, Baltimore, MD 21287, USA. mkoga3@jhmi.edu
Anthony V Serritella
Marcus M Messmer
Akiko Hayashi-Takagi
Lynda D Hester
Solomon H Snyder
Akira Sawa
Thomas W Sedlak
Johns Hopkins Medicine · USJohns Hopkins University · USThe University of Tokyo · JP

Funding

NEUROCHEMICAL ACTIONS OF PSYCHOTROPIC DRUGSR37MH018501 · NIMH · JOHNS HOPKINS UNIVERSITY · PI SNYDER, SOLOMON H. · 1990 to 2009
$11.5M
NEUROCHEMICAL ACTIONS OF PSYCHOTROPIC DRUGSR01MH018501 · NIMH · JOHNS HOPKINS UNIVERSITY · PI SNYDER, SOLOMON H. · 1985 to 2019
$10.8M
Research Center for Molecular Pathogenesis of SchizophreniaP20MH084018 · NIMH · JOHNS HOPKINS UNIVERSITY · PI VALLE, DAVID · 2008 to 2010
$3.3M
Oxidative stress and schizophrenia: combination of cell biology and brain imagingR01MH092443 · NIMH · JOHNS HOPKINS UNIVERSITY · PI SAWA, AKIRA · 2011 to 2015
$1.8M
Cell signaling and cytoprotective roles of biliverdin reductaseK08NS057824 · NINDS · JOHNS HOPKINS UNIVERSITY · PI SEDLAK, THOMAS WILLIAM · 2008 to 2011
$708k
NIMH NIH HHS MH 084018NIMH NIH HHS MH 092443NIMH NIH HHS MH 18501NIMH NIH HHS P20 MH084018NIMH NIH HHS R01 MH018501NIMH NIH HHS R01 MH092443NIMH NIH HHS R37 MH018501NINDS NIH HHS 1K08NS057824NINDS NIH HHS K08 NS057824
6 · The paper itself

Abstract

Glutamate, the principal excitatory neurotransmitter of the brain, participates in a multitude of physiologic and pathologic processes, including learning and memory. Glutathione, a tripeptide composed of the amino acids glutamate, cysteine, and glycine, serves important cofactor roles in antioxidant defense and drug detoxification, but glutathione deficits occur in multiple neuropsychiatric disorders. Glutathione synthesis and metabolism are governed by a cycle of enzymes, the γ-glutamyl cycle, which can achieve intracellular glutathione concentrations of 1-10mM. Because of the considerable quantity of brain glutathione and its rapid turnover, we hypothesized that glutathione may serve as a reservoir of neural glutamate. We quantified glutamate in HT22 hippocampal neurons, PC12 cells and primary cortical neurons after treatment with molecular inhibitors targeting three different enzymes of the glutathione metabolic cycle. Inhibiting 5-oxoprolinase and γ-glutamyl transferase, enzymes that liberate glutamate from glutathione, leads to decreases in glutamate. In contrast, inhibition of γ-glutamyl cysteine ligase, which uses glutamate to synthesize glutathione, results in substantial glutamate accumulation. Increased glutamate levels following inhibition of glutathione synthesis temporally precede later effects upon oxidative stress.

Indexed as

AnimalsButhionine SulfoximineCell Line, TumorEnzyme Inhibitorsgamma-GlutamyltransferaseGlutamic AcidGlutathioneHippocampusImidazolinesIsoxazolesMiceNeuronsPyroglutamate HydrolaseRats2-imidazolidone-4-carboxylic acidacivicinButhionine SulfoximineEnzyme Inhibitorsgamma-GlutamyltransferaseGlutamic AcidGlutathioneImidazolinesIsoxazolesPyroglutamate Hydrolase

Identifiers

PMID21539809
PMCPMC3923312
OpenAlexW2027589595

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.